You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

AEROBID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Aerobid, and what generic alternatives are available?

Aerobid is a drug marketed by Roche Palo and is included in one NDA.

The generic ingredient in AEROBID is flunisolide. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the flunisolide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Aerobid

A generic version of AEROBID was approved as flunisolide by BAUSCH on February 20th, 2002.

  Try a Trial

US Patents and Regulatory Information for AEROBID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo AEROBID flunisolide AEROSOL, METERED;INHALATION 018340-001 Aug 17, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for AEROBID

See the table below for patents covering AEROBID around the world.

Country Patent Number Title Estimated Expiration
Philippines 13398 USE OF FLUNISOLIDE TO TREAT RESPIRATORY DISEASES ⤷  Try a Trial
Netherlands 7605699 ⤷  Try a Trial
New Zealand 183905 AEROSOL COMPOSITIONS FOR NASAL OR INHALATION ADMINISTRATION CONTAINING 6 -FLUORO-11 , 21-DIHYDROXY-16 ,17 -ISOPROPYLIDENEDIOXY-PREGNA-1,4-DIENE-3,20-DIONE ⤷  Try a Trial
Japan S62281817 NASAL SPRAY LIQUID ⤷  Try a Trial
Malaysia 8000275 NEW FORM OF FLUNISOLIDE AND THE USE OF FLUNISOLIDE TO TREAT RESPIRATORY DISEASES ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.